Mumbai, Maharashtra, India, February 2026 — Zydus MedTech has appointed Arvind Bothra as its Chief Financial Officer, effective February 2026. In addition to this role, he will continue to serve as Head of Investor Relations at Zydus Lifesciences Limited, ensuring continuity across the Group’s financial strategy and investor engagement.
In his new role, Arvind Bothra will oversee the financial leadership of Zydus MedTech as it strengthens its position in the global medical technology space. His appointment reflects the organisation’s focus on disciplined financial management, strategic capital allocation, and long-term value creation, while maintaining strong alignment with the broader Zydus Group.
Prior to this appointment, Arvind Bothra served as Chief Financial Officer at Zydus Healthcare Limited, a wholly owned subsidiary of Zydus Lifesciences, where he played a key role in financial stewardship and governance. Alongside this, he has been serving as Senior Vice President – Investor Relations and Strategic Initiatives in the Managing Director’s Office at Zydus Group, leading investor communications and supporting strategic initiatives at the Group level.
Earlier in his career, he held senior leadership roles in investor relations, mergers and acquisitions, and corporate strategy across leading pharmaceutical and financial services organisations, including Aurobindo Pharma, Lupin, Tata Capital, Motilal Oswal Financial Services, Religare Capital Markets, and Bank of America Merrill Lynch, building deep expertise in capital markets, stakeholder engagement, and financial analysis.
Arvind Bothra began his professional journey in consulting and finance, with early experience at KPMG Advisory Services and PwC, laying a strong foundation in financial advisory and corporate finance. He holds an MBA in Finance and Strategy from the Indian Institute of Management, Lucknow.
About Zydus MedTech
Zydus MedTech is a wholly owned subsidiary of Zydus Lifesciences, backed by a healthcare legacy spanning over seven decades and a presence in more than 85 countries. The company is focused on advancing patient care through precision manufacturing, R&D excellence, and meaningful clinical collaboration, delivering purpose-driven and globally compliant medical technology solutions.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
